Microsatellite instability (MSI) is a com mon feature of gastric cancers th
at reflects underlying mismatch-repair deficiency in the tumor, caused most
frequently by methylation of the hMLH1 promoter, Tumors with MSI have been
found to inactivate certain target genes by permitting an increased freque
ncy of mutations in mononucleotide runs in their coding regions. Gastric tu
mors with MSI have a distinct clinicopathological profile with a relatively
good prognosis. Using the simple and robust methodologies available, MSI d
etection in gastrointestinal tumors promises to be one of the first widely
used molecular prognostic tests for human cancer. Here, we review the molec
ular context of this exciting prospect with respect to one of the world's m
ost prevalent cancers, that of the stomach.